Home › NDC Lookup › RxCUI directory › RxCUI 1150836

Levobunolol hydrochloride 5 MG/ML Ophthalmic Solution — RxCUI 1150836

RxNorm drug concept · Semantic clinical drug
RxCUI 1150836 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1150836
Official nameLevobunolol hydrochloride 5 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevobunolol hydrochloride 0.5 % Ophthalmic Solution; levobunolol HCl 0.5 % Ophthalmic Solution
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)2,275 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levobunolol Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers pressure inside your eye. Doctors prescribe it for chronic open-angle glaucoma or ocular hypertension. Keeping eye pressure down helps protect your optic nerve and vision...
  • It is usually started as one to two drops in the affected eye(s) once a day. Some people with tougher-to-control glaucoma use it twice a day. Follow your prescriber's directions, s...
  • It can. Temporary burning or stinging happened in up to 1 in 3 people in studies. Call your doctor if it is bothersome or you notice eyelid redness, swelling or vision changes.
  • You should not use it if you have asthma, a history of asthma or severe COPD. It is also not for people with a very slow heart rate, heart block, heart failure or cardiogenic shock...
📖 Read our full Levobunolol Ophthalmic guide →

🕸️ Concept Web — How Levobunolol hydrochloride 5 MG/ML Ophthalmic Sol... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levobunolol hydrochloride 5 MG/ML Ophthalmic Solution RxCUI 1150836

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Levobunolol 1813
    • Levobunolol hydrochloride 227212
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levobunolol Ophthalmic Solution 377438
    • Levobunolol hydrochloride Ophthalmic Solution 2647168
    • Levobunolol Ophthalmic Product 1163454
    • Levobunolol hydrochloride Ophthalmic Product 2661337
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levobunolol hydrochloride 5 MG/ML 1150835

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levobunolol hydrochloride 5 MG/ML SCDC · 1150835
  • Levobunolol Ophthalmic Solution SCDF · 377438
  • Levobunolol hydrochloride Ophthalmic Solution SCDFP · 2647168
  • Levobunolol Ophthalmic Product SCDG · 1163454
  • Levobunolol hydrochloride Ophthalmic Product SCDGP · 2661337

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 1150836 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0505-05 1 BOTTLE, DROPPER in 1 CARTON (24208-505-05) / 5 mL in 1 BO... Levobunolol Hydrochloride Bausch & Lomb Incorporated 1994-03-04
24208-0505-10 1 BOTTLE, DROPPER in 1 CARTON (24208-505-10) / 10 mL in 1 B... Levobunolol Hydrochloride Bausch & Lomb Incorporated 1994-03-04
24208-0505-15 1 BOTTLE, DROPPER in 1 CARTON (24208-505-15) / 15 mL in 1 B... Levobunolol Hydrochloride Bausch & Lomb Incorporated 1994-03-04
Observed labelers: Bausch & Lomb Incorporated (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$2.7356
Range $2.7356–$2.7356 · middle 50% $2.7356–$2.7356 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.